Improving Outcomes Assessment in Chronic GVHD

StatusActive, Not Recruiting
PhaseNot specified
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Study completion pushed from Feb 2027 to Feb 2028
    • Eligibility criteria expanded, about 11 words
    • Publications: details revised at 7 of 7 entries
  2. 2 versions Re-verified since Oct 2, 2025, no change to tracked fieldsv30-v31
  3. Study completion date: Feb 2026 to Feb 2027v29
  4. Re-verified, no change to tracked fieldsv28
  5. Study completion date: Feb 2025 to Feb 2026v27
Show 25 earlier versionsHide 25 earlier versions
  1. 6 versions Re-verified since Sep 2, 2020, no change to tracked fieldsv21-v26
  2. Study completion date: Feb 2020 to Feb 2025v20
  3. Primary completion date: May 2014 to May 2017v19
  4. Study completion date: Jun 2018 to Feb 2020v18
  5. Collaborators: 8 to 9v17
  6. Re-verified, no change to tracked fieldsv16
  7. Study completion date: May 2015 to Jun 2018v15
  8. Study completion date: May 2014 to May 2015v14
  9. Primary and study completion dates: May 2013 to May 2014v13
  10. Enrollment target: 602 to 601v12
  11. Trial status: Enrolling by Invitation to Active, Not Recruitingv11
  12. Primary and study completion dates pushed to May 2013v10 Show 4 more changesShow less
    • Trial status: Recruiting to Enrolling by Invitation
    • Enrollment target: estimated 672 to confirmed 602
    • Site details revised at 9 of 9 sites
    • Collaborators: 7 to 8
  13. Study sites: 8 to 9
    • Primary completion date: Jun 2012 to May 2012
    • Study completion date: Jun 2012 to Dec 2012
    • Eligibility criteria revised
    v9
  14. Collaborators: 9 to 7v8
  15. Study sites: 9 to 8v7
  16. Study sites: 8 to 9v6
  17. Study sites: 6 to 8
    • Collaborators: 6 to 9
    v5
  18. Study sites: 5 to 6
    • Eligibility criteria revised
    • Collaborators: 5 to 6
    v4
  19. Re-verified, no change to tracked fieldsv3
  20. Site details revised at 2 of 5 sitesv2
  1. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is to see if recent guidelines proposed by the National Institutes of Health for the diagnosis, staging, and response assessment of people with chronic GVHD can improve our understanding of this complication. We will accomplish our goals by studying a large number of people with chronic GVHD over several years using information collected from health care providers, patients, laboratory studies and diagnostic tests. Several transplant centers in the United States are collaborating on this project.
Trial Details
NCT Number NCT00637689
Lead Sponsor Fred Hutchinson Cancer Center
Collaborators: University of Minnesota, Stanford University, Dana-Farber Cancer Institute, Vanderbilt University, Medical College of Wisconsin, Washington University School of Medicine, H. Lee Moffitt Cancer Center and Research Institute, Memorial Sloan Kettering Cancer Center, National Cancer Institute (NCI)
Conditions
(from sponsor)		 Chronic Graft Versus Host Disease
Related terms Bronchiolitis Obliterans Syndrome
Enrollment 601 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov